Showing results (291-300 of 999) with videos related to

Sort By:
Pageof 100
Ejhaem|August 21, 2023
Immune response to COVID-19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapyKatherine Rankin, Priyanka Hastak, Alexander Wong, et al.
Ejhaem|August 21, 2023
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trialPedro Marques Ramos, Jeea Choi, Catarina D Campbell, et al.
Ejhaem|August 21, 2023
Comparative analysis of opioid use in sickle cell crisis in an urban facility in GhanaMarian Opoku-Agyakwa, Henry J Lawson, Edeghonghon Olayemi
Ejhaem|August 21, 2023
Monocytic and blastic plasmacytoid dendritic cell differentiation in acute leukemia with KMT2A rearrangementOwen Xue, Choladda V Curry, Hong Fang, et al.
Ejhaem|August 21, 2023
Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapySøren Thorgaard Bønløkke, Marianne Tang Severinsen, Hans Beier Ommen, et al.
Ejhaem|August 21, 2023
Normalisation of haemoglobin and control of breakthrough haemolysis with increased frequency pegcetacoplan dosing in treated paroxysmal nocturnal haemoglobinuriaAmanda K Davis, Nicholas Bingham, Jeff Szer
Ejhaem|September 2, 2022
Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndromeJahanzaib Khwaja, Ryan Keh, Duncan Smyth, et al.
Ejhaem|September 2, 2022
Developmental disorders in children born to women with sickle cell disease: A report from the Boston Birth CohortMartha Brucato, Eboni Lance, Sophie Lanzkron, et al.
Ejhaem|September 2, 2022
Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficaciousKoffi Mawuse Guedenon, Mawouto Fiawoo, Djatougbe Ayaovi Elie Akolly, et al.
Ejhaem|September 2, 2022
Unmet needs in the management of immune-mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK-A modified-Delphi studyMarie Scully, Tina Dutt, Will Lester, et al.
Pageof 100